Drug
Musk Caart
Musk Caart: highest development phase Phase 1, developed by Cabaletta Bio. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Cabaletta Bio
Trials
| Drug | Phase | Indication |
|---|---|---|
| MuSK-CAART NCT05451212 | Phase 1 | MuSK Myasthenia Gravis |
Latest
No recent events.
Follow Musk Caart on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.